U.S. markets close in 4 hours
  • S&P 500

    3,974.65
    +11.14 (+0.28%)
     
  • Dow 30

    33,824.64
    +43.16 (+0.13%)
     
  • Nasdaq

    11,130.23
    +48.22 (+0.44%)
     
  • Russell 2000

    1,813.33
    -4.96 (-0.27%)
     
  • Crude Oil

    72.32
    +0.86 (+1.20%)
     
  • Gold

    1,817.70
    +16.20 (+0.90%)
     
  • Silver

    23.89
    +0.64 (+2.77%)
     
  • EUR/USD

    1.0552
    -0.0008 (-0.07%)
     
  • 10-Yr Bond

    3.5470
    +0.0560 (+1.60%)
     
  • GBP/USD

    1.2310
    +0.0072 (+0.59%)
     
  • USD/JPY

    136.3910
    -0.2390 (-0.17%)
     
  • BTC-USD

    17,182.62
    +246.63 (+1.46%)
     
  • CMC Crypto 200

    404.81
    -1.44 (-0.35%)
     
  • FTSE 100

    7,476.63
    +4.46 (+0.06%)
     
  • Nikkei 225

    27,901.01
    +326.58 (+1.18%)
     

Why Glaukos Stock Zoomed Nearly 19% Higher Today

Glaukos (NYSE: GKOS), a specialty healthcare company that concentrates on eye disorders, enjoyed a very healthy pop in its share price on Wednesday. This followed the company's latest clinical update. The drug also demonstrated a favorable safety profile and was extremely well tolerated, Glaukos said.